Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclazocine revisited

S Archer1, S D Glick, J M Bidlack

  • 1Department of Chemistry, Rensselaer Polytechnic Institute, Troy, NY 12180-3590, USA.

Neurochemical Research
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Benefits of a Rapid Access Pathway for Patients Requiring Single Fraction Radiotherapy Treatment: The Cambridge Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Readmissions to hospital following a decision to eat and drink with acknowledged risk.

Geriatric nursing (New York, N.Y.)·2023
Same author

Genetic investigation of equine recurrent uveitis in Appaloosa horses.

Animal genetics·2019
Same author

Public acceptability of nudging and taxing to reduce consumption of alcohol, tobacco, and food: A population-based survey experiment.

Social science & medicine (1982)·2019
Same author

Effects of simulated grazing on foliage and root production and biomass allocation in an arctic tundra sedge (Eriophorum vaginatum).

Oecologia·2017
Same author

Variant in the RFWD3 gene associated with PATN1, a modifier of leopard complex spotting.

Animal genetics·2015
Same journal

MST4 Regulates Microglia Neuroinflammation via Targeting PKM2 Nuclear Translocation in Epilepsy: An In Vivo and In Vitro Study.

Neurochemical research·2026
Same journal

Correction to: Dual Antioxidant DH-217 Mitigated Cerebral Ischemia-Reperfusion Injury by Targeting IKKβ/Nrf2/HO-1 Signal Axis.

Neurochemical research·2026
Same journal

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026
Same journal

Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway.

Neurochemical research·2026
Same journal

Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation.

Neurochemical research·2026
Same journal

Long-Term Impact of Early-Life Stress on Hippocampal Apoptotic Gene Expression in BALB/c Mice.

Neurochemical research·2026
See all related articles

New compounds with long-term mu antagonist and short-term kappa agonist effects block cocaine and morphine self-administration in rats. Cyclazocine demonstrates these properties, preventing drug intake despite initial side effects.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Addiction Research

Background:

  • Opioid receptors, specifically mu and kappa, play critical roles in the rewarding effects of drugs.
  • Compounds modulating these receptors are investigated for potential addiction treatments.
  • Cyclazocine, a known opioid receptor ligand, has a history of study for its complex pharmacological profile.

Purpose of the Study:

  • To evaluate the efficacy of compounds with dual mu antagonist and kappa agonist properties in preventing drug self-administration.
  • To assess the long-term effects and side effect profiles of such compounds, using cyclazocine as a model.
  • To determine if tolerance develops to the therapeutic or adverse effects of these compounds.

Main Methods:

  • Administration of novel compounds and cyclazocine to rats.

Related Experiment Videos

  • Assessment of drug self-administration behaviors (cocaine and morphine).
  • Observation and recording of drug-induced side effects and development of tolerance in human subjects.

    • Main Results:

    • Compounds with long-term mu antagonism and short-term kappa agonism effectively prevented cocaine and morphine self-administration in rats.
    • Cyclazocine, exhibiting these receptor activities, also blocked drug self-administration in rats.
    • While human subjects experienced transient side effects, tolerance developed to these, but not to the mu antagonist actions.

    Conclusions:

    • Compounds combining long-term mu antagonism with short-term kappa agonism show promise for blocking drug reinforcement.
    • Cyclazocine's profile supports its potential as a therapeutic agent for substance use disorders, particularly regarding its sustained antagonist action.
    • Tolerance to side effects without loss of therapeutic effect suggests a viable treatment window for these compounds.